Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
News Medical on MSN
New trial tests strategies to protect heart health during prostate cancer therapy
City of Hope ® , one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation's top cancer centers by ...
An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.
Enolen's fast track designation by the FDA aims to expedite its development for localized prostate cancer treatment, addressing unmet medical needs. The localized delivery technology targets ...
SurvivorNet on MSN
Prostate cancer screening: Simple, smart, life-saving
An article about the importance of PSA testing for early detection and treatment of prostate cancer ...
While many think of walking as a great exercise to keep you active, even as you get older, experts have found that tennis is ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--Alessa Therapeutics (“Alessa”), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology for the treatment of early-stage ...
A raft of new tests and technologies to spot cases of the disease earlier will also be assessed by the NHS spending watchdog ...
Alessa Therapeutics (“Alessa”), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology for the treatment of early-stage prostate cancers, today announced that ...
Scott Adams, creator of the comic strip “Dilbert,” has died after being diagnosed with metastatic prostate cancer. He was 68. The cartoonist’s former wife Shelly Miles announced his death in a ...
Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on ...
SECuRE trial to continue with no modifications to protocol following Safety Review Committee meeting
HIGHLIGHTSFollowing an interim data review of the Cohort Expansion Phase (Phase II) of the SECuRE trial, the Safety Review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results